These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney. Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Wakino S; Saruta T J Cardiovasc Pharmacol; 1999 Feb; 33(2):243-7. PubMed ID: 10028932 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the renal effects of calcium antagonists. Ruilope LM; Lahera V; Rodicio JL J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S49-53. PubMed ID: 7609506 [TBL] [Abstract][Full Text] [Related]
24. Renal haemodynamic and protective effects of calcium antagonists in hypertension. Zanchi A; Brunner HR; Waeber B; Burnier M J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898 [TBL] [Abstract][Full Text] [Related]
25. Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity. Seyss C; Foote EF Ann Pharmacother; 1995 Feb; 29(2):187-8. PubMed ID: 7756720 [TBL] [Abstract][Full Text] [Related]
26. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension. Hayashi K; Ozawa Y; Fujiwara K; Wakino S; Kumagai H; Saruta T Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599 [TBL] [Abstract][Full Text] [Related]
27. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hayashi K; Ozawa Y; Wakino S; Kanda T; Homma K; Takamatsu I; Tatematsu S; Saruta T J Cardiovasc Pharmacol; 2003 Dec; 42(6):697-702. PubMed ID: 14639089 [TBL] [Abstract][Full Text] [Related]
28. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. Bunke M; Ganzel B J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446 [TBL] [Abstract][Full Text] [Related]
38. Renal protection with calcium antagonists: the role of lercanidipine. Burnier M Curr Med Res Opin; 2013 Dec; 29(12):1727-35. PubMed ID: 24069902 [TBL] [Abstract][Full Text] [Related]
39. Attempts to improve the selectivity of calcium antagonistic drugs. van Zwieten PA; Pfaffendorf M; Mancia G Blood Press Suppl; 1996; 5():7-9. PubMed ID: 8973786 [TBL] [Abstract][Full Text] [Related]
40. [Therapy of hypertension with calcium antagonists. Heart and kidney protection for elderly type 2 diabetic patients]. Keil TU MMW Fortschr Med; 2000 Mar; 142(11):18. PubMed ID: 10786084 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]